Legal Representation
Attorney
Jacqueline Zion
USPTO Deadlines
Next Deadline
1209 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20230530)
Due Date
May 30, 2029
Grace Period Ends
November 30, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
44 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 30, 2023 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| May 30, 2023 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Apr 25, 2023 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Apr 24, 2023 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Apr 6, 2023 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Apr 3, 2023 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Apr 3, 2023 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Nov 1, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 31, 2022 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Oct 25, 2022 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Oct 25, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 29, 2022 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Jun 29, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jun 29, 2022 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Jun 23, 2022 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Apr 8, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 8, 2022 | NOAC | E | CORRECTED NOA E-MAILED | Loading... |
| Apr 7, 2022 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Mar 23, 2022 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Apr 7, 2022 | DPCC | D | DIVISIONAL PROCESSING COMPLETE | Loading... |
| Mar 23, 2022 | DRRR | I | DIVISIONAL REQUEST RECEIVED | Loading... |
| Apr 7, 2022 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Mar 23, 2022 | ERTD | I | TEAS REQUEST TO DIVIDE RECEIVED | Loading... |
| Mar 23, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 28, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 26, 2021 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Oct 26, 2021 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Oct 26, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 17, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 15, 2021 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Apr 15, 2021 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Apr 15, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 21, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 19, 2020 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Oct 19, 2020 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Oct 19, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 28, 2020 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Mar 3, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Mar 3, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Feb 12, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jan 24, 2020 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 23, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 21, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Oct 21, 2019 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Biopharmaceuticals for the treatment of erectile dysfunction and sexual dysfunctions and disorders, and for the maintenance of sexual health
First Use Anywhere:
Aug 24, 2022
First Use in Commerce:
Aug 24, 2022
Class 042
Product development in the field of biopharmaceuticals for the treatment of erectile dysfunction and sexual dysfunctions and disorders, and for the maintenance of sexual health
First Use Anywhere:
Dec 14, 2017
First Use in Commerce:
Dec 14, 2017
Classification
International Classes
005
042